Baraclude Related Clinical Trials
Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis [Enrolling by invitation]
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders [Recruiting]
Suboptimal Responders to Adefovir Switching to Entecavir [Recruiting]
Comparison Between Lamivudine and Entecavir Treatment in Patients [Not yet recruiting]
Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B [Recruiting]
Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA [Recruiting]
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA [Recruiting]
Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment [Not yet recruiting]
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B [Recruiting]
Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients [Recruiting]
Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) [Recruiting]
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B [Recruiting]
Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B [Recruiting]
Switching to Tenofovir Versus Continuing Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response During Entecavir Therapy: STEEP Study [Not yet recruiting]
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B [Recruiting]
Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment [Recruiting]
Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B [Recruiting]
Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir [Recruiting]
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma [Recruiting]
Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B [Recruiting]
Lactic Acidosis During Entecavir(ETV)Treatment [Not yet recruiting]
Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir [Recruiting]
Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B [Recruiting]
Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection [Not yet recruiting]
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B [Recruiting]
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA [Recruiting]
Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B [Recruiting]
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection [Recruiting]
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection [Recruiting]
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection [Recruiting]
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. [Recruiting]
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection [Recruiting]
A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a (40KD))and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B [Recruiting]
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B [Recruiting]
Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy [Recruiting]
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B [Recruiting]
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus [Recruiting]
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation [Active, not recruiting]
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection [Completed]
Entecavir Plus Adefovir in Lamivudine-Resistant Patients [Not yet recruiting]
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B. [Recruiting]
Simvastatin for the Treatment of Chronic Hepatitis B [Recruiting]
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis B [Recruiting]
Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection [Not yet recruiting]
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection [Recruiting]
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B [Recruiting]
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B [Active, not recruiting]
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection [Recruiting]
Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program [Available]
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection [Recruiting]
Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients [Completed]
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease. [Active, not recruiting]
Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients [Recruiting]
A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine [Completed]
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen [Completed]
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen [Completed]
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B [Recruiting]
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma [Recruiting]
Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma [Recruiting]
Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B [Completed]
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B [Recruiting]
|